RankAlpha logo
Back to Rankings

LCTX

Lineage Cell TherapeuticsF
NYSE American / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-22
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
LCTX vs peer average
36/100
LCTX vs. peer average (F vs. D)
Grade spread
C 2 · D 3 · F 3
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

SLGL is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $275.58M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerSLGLSol-Gel
LCTX
Lineage Cell Therapeutics
SLGL
Sol-Gel
Grade
F
D
Momentum
0
68
Value
41
48
Sentiment
-
29
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs SLGL

LCTX / SLGL
Grade Position
Below peers
LCTX vs. peer average (F vs. D)
36/100
Momentum
0
SLGL
Value
41
SLGL
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs LCTX
1
SLGL
Sol-Gel Technologies Ltd Common
D
40/100
-1
2
SABS
SAB Biotherapeutics Inc Common
D
40/100
-1
3
MGNX
MacroGenics Inc Common
C
60/100
-2
4
TKNO
Alpha Teknova Inc Common
F
20/100
Even
5
ALXO
ALX Oncology Holdings Inc Common
F
20/100
Even
SLGL is the first peer returned for this comparison set.